Ultrahuman, the pioneering health optimisation company behind the Ultrahuman Ring and M1 - the advanced CGM platform, today announced the nationwide expansion of Blood Vision, now available across 48 U.S. states.
Unlike traditional blood testing services that offer static snapshots, Blood Vision combines deep biomarker analysis with real-time wearable data to create the most advanced consumer-facing system for longitudinal health tracking, early risk detection, and lifestyle-driven interventions.
Blood Vision offers 100+ select biomarkers across cardiovascular, metabolic, hormonal, inflammatory, and longevity-related pathways. Each biomarker is selected for its clinical relevance and predictive power. These range from hs-CRP for inflammation to ApoB for cardiovascular risk and fasting insulin for early metabolic dysfunction.
● Cardiovascular: ApoB, Lp(a)
● Metabolic: Fasting insulin, HOMA-IR
● Hormonal: Free testosterone, TSH
● Inflammatory: hs-CRP, IL-6
● Longevity: Biological age metrics
Blood Vision stands apart by going beyond static lab results. Using UltraTrace™ technology, users can now integrate their blood markers with lifestyle markers such as sleep, movement, and recovery data via the Ultrahuman Ring – as well as glucose patterns from CGM.
By linking blood chemistry to daily behaviours, Blood Vision offers a personalized health model where cause and effect are visible and actionable in real time. Research shows¹ that frequent, longitudinal tracking of multimodal data, when combined with lifestyle metrics, can significantly improve the early detection of chronic disease.
All results are delivered through a unified dashboard within the Ultrahuman app, making trends, risks, and insights easy to act on.
The platform also includes a follow-up test to track longitudinal changes, empowering users to measure and optimise progress over time. It’s a vital part of the feedback loop that enables Blood Vision to improve health.
“Traditional diagnostics offer a moment-in-time snapshot,” said Mohit Kumar, Founder and CEO of Ultrahuman. “Blood Vision transforms this into a longitudinal, predictive model of your health – where insights evolve as you do, and interventions are guided by both real-time lifestyle data and blood marker analysis. The real magic is in between two blood vision tests. Tracking lifestyle biomarkers between two tests allows us to establish the relationship between the biomarkers and lifestyle changes. Most people lose track of what to change between two tests; blood vision bridges this gap."
Users gain access to AI clinician summaries, comprehensive supplementary reports, and performance coaching to translate insights into action. These reports also incorporate UltraTrace™ technology to offer a holistic analysis of health and lifestyle markers.
This model of integrated, personalised, and actionable health data represents a shift from reactive care to proactive optimisation – from episodic testing to real-time adaptation, and from a static health snapshot to a dynamic blueprint for longevity.
